Compare Citius Pharmaceuticals Inc (CTXR) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Warner Music Group Corp — how do they compare? Citius Pharmaceuticals Inc trades at $0.77 (market cap $20.01M), while Warner Music Group Corp trades at $24.85 (market cap $13.12B). The key difference: Warner Music Group Corp is far larger — about 655.7× Citius Pharmaceuticals Inc's market cap, and Warner Music Group Corp pays a 3.19% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | WMG | |
|---|---|---|
Market Cap | $20.01M | $13.12B |
Sector | Health | Media |
52-Week High | $1.82 | $34.72 |
52-Week Low | $0.48 | $23.65 |
Enterprise Value | $16.23M | $17.42B |
Dividend Yield | — | 3.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTXR trades at $0.7554, up 11.58% today, with a bullish technical signal from moving averages. The company reported a net loss of $37.43M for 2025, with a negative net income margin of -823.34%, but shows revenue growth from its LYMPHIR launch. Recent news highlights commercial expansion and positive clinical data presentations at ASCO 2026.
The outlook is speculative; analyst consensus is strongly bullish (83.3% Buy), but high cash burn and consistent earnings misses pose significant risks. Investment potential hinges on successful commercialization of LYMPHIR to achieve profitability.
Warner Music Group (WMG) trades at $24.62, down 6.78% in the past 24 hours, reflecting bearish technical momentum. The stock shows mixed fundamentals with recent earnings beats in Q1 and Q2 2026 but declining net income margins from 9.3% in 2022 to 5.44% in 2025. Strong institutional buying interest and a 66.66% analyst buy rating provide support despite near-term weakness.
WMG presents a compelling value opportunity with reasonable valuation multiples (P/E 20.06, P/S 1.8) and robust 9.2% projected 2026 net margin. Key risks include leadership transitions following the CFO's departure and streaming market competition, but strategic partnerships and price increases support long-term growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
